Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Sodium Cyclamate USP

Sodium Cyclamate USP

139-05-9

DISCOVER
Sorafenib

Sorafenib

284461-73-0

DISCOVER
Scopolamine

Scopolamine

51-34-3

DISCOVER
Serricornine

Serricornine

72522-40-8

DISCOVER
Sulfaclozine sodium monohydrate

Sulfaclozine sodium monohydrate

1392129-96-2

DISCOVER
Ethyl Salicylate

Ethyl Salicylate

118-61-6

DISCOVER
Sitagliptin Phosphate monohydrate

Sitagliptin Phosphate monohydrate

654671-77-9

DISCOVER
(N,N-didemethyl) 1-Hydroxy Sibutramine Hydrocholride

(N,N-didemethyl) 1-Hydroxy Sibutramine Hydrocholride

186521-88-0

DISCOVER
N-Desmethyl-N-benzyl Sildenafil

N-Desmethyl-N-benzyl Sildenafil

1446089-82-2

DISCOVER
Spectinomycin HCl

Spectinomycin HCl

1695-77-8

DISCOVER
Sodium Cyclamate

Sodium Cyclamate

139-05-9

DISCOVER
Strychnine

Strychnine

57-24-9

DISCOVER